Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 111 results for "novartis india"

Novartis India dips after board approves share buyback
Business Standard India

Novartis India Ltd to approve Q1 results on July 28, 2016

A meeting of the Board of Directors of Novartis India Ltd will be held on July 28, 2016, to consider unaudited financial results of the Company for first quarter ended June 30, 2016. Shares of NOVARTIS INDIA LTD. was last trading in BSE at Rs.731.2 ... Equity Bulls, 2 days ago

30 images for novartis india, 1 month ago, 1 month ago
Business Standard India, 1 month ago
Financial Express, 1 month ago
India Infoline, 1 month ago
Financial Express, 1 month ago, 2 months ago, 2 months ago
Yahoo! India, 2 months ago
MyNewsDesk, 2 months ago

Novartis India to hold board meeting

On 28 July 2016
 Business Standard4 days ago Novartis India to hold AGM  Capital Market1 month ago Board of Novartis India recommends final dividend  Capital Market1 month ago

Novartis India to turn ex-date for buyback

Shares of Novartis India may remain in focus, as they will turn ex-date for the proposed buyback. The company plans to buy back 38.2 lakh shares (or 11.95 per cent of the total paid-up equity capital), from all the shareholders, including promoters, on a ...
 Business Line4 days ago Novartis India shares jump over 17% on buyback plan  Economic Times2 months ago Novartis India surges as company mulls share buyback plan  Economic Times2 months ago

Novartis India fixes record date for buyback of shares

Record date is 22 July 2016
 Business Standard1 week ago Novartis India Ltd Fixes Record Date for Buyback  Equity Bulls1 week ago

Conference on drug counterfeiting organised in Mumbai

Usha Sharma- Mumbai SynCore Consulting, in collaboration with Organisation of Pharmaceutical Producers of India (OPPI), AIOCD, Indian Medical Association (IMA), Indian Pharmaceutical Association (IPA), Indian Drug Manufacturers Association ...
 CPhI.cn1 week ago

SPJIMR launches programme for NGOs working in cancer care

The one-year Organisational Development Programme is conceived, developed and delivered by SPJIMR's Centre for Education in the Social Sector and is supported by Novartis India The SP Jain Institute of Management and Research (SPJIMR), a leading ...
 Express Pharma2 days ago 1-year course launched for NGOs supporting cancer patients  Times of India2 months ago

Sun Pharma brings back old hand Kalyanasundaram Subramanian from Taro Pharmaceutical Industries

MUMBAI: Kalyanasundaram Subramanian, or Kal Sundaram, an old hand at Sun Pharmaceutical Industries, is coming back home. He will be leading the India and sub-continent business starting January 2017. Post the acquisition of Ranbaxy, Sun has taken ...
 Economic Times1 week ago
Money Today

Novartis stock closes 12.45% lower on Q4 earnings

Novartis India on Thursday reported a standalone net profit of Rs 21.5 crore for the March quarter. It had posted a net profit of Rs 51.9 crore in the same period a year ago. "The figures for the year ended March 31, 2016 are not comparable to those of the ...
 Money Today1 month ago Novartis shares slide 13 per cent after Q4 results  Financial Express1 month ago Novartis India shares slide as much as 13% after Q4 results  Livemint.com1 month ago Novartis Slumps On Q4 Result Disappointment  NDTV1 month ago

Novartis India tumbles as buyback plan disappoints investors

after the company's buyback plan disappointed investors. The company announced its buyback plan after market hours yesterday, 26 May 2016. Meanwhile, the S BSE Sensex was up 181.32 points or 0.69% at 26,550.90. More than usual volumes were witnessed on the ...
 Business Standard1 month ago Novartis India slumps after reporting dismal Q4 numbers  Business Standard1 month ago Novartis Posts Rs 22 Crore Profit In Q4  NDTV1 month ago Novartis Q4 Net at Rs 22cr;share buyback plan gets board's nod  Times of India1 month ago
Financial Express

Novartis India to buy back shares worth Rs 290 crore

Novartis India, which sells the oncology drug Glivec, said on Thursday it will buy back shares worth Rs 290 crore. In a stock exchange filing, the pharmaceutical company said it would acquire close to 38 lakh shares at a price of Rs 760 a share. The ...
 Financial Express1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less